» Articles » PMID: 29312705

Anemia As a Clinical Marker of Stable Chronic Obstructive Pulmonary Disease in the Korean Obstructive Lung Disease Cohort

Overview
Journal J Thorac Dis
Specialty Pulmonary Medicine
Date 2018 Jan 10
PMID 29312705
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Anemia is a major co-morbidity in chronic obstructive pulmonary disease (COPD). However, the mechanism of development for anemia and the impact of anemia on the prognosis of COPD remain poorly understood. Therefore, this study attempted to evaluate the prognostic role of anemia on the clinical course of COPD and investigate the factors linked with the serum hemoglobin level in COPD.

Methods: We analyzed 407 COPD patients enrolled in the Korean obstructive lung disease (KOLD) cohort at 16 hospitals in Korea recruited over 9 years. Multivariate Cox regression analysis was performed to find independent predictors of survival and multivariate logistic regression analyses were done to find independent factors.

Results: Anemic COPD were older with lower body mass index (BMI) (P<0.001), lower serum cholesterol level (P=0.001), lower serum albumin level (P<0.001), and shorter 6-minute walking distance (P=0.046) compared to non-anemic COPD. A multivariate Cox regression analysis revealed that age (P=0.002), BMI (P=0.001), post-bronchodilator forced expiratory volume in 1 second (FEV) (P=0.007), 6-minute walk distance (P=0.008), anemia (P=0.025) were significant predictors for all-cause mortality. In multivariate regression analysis, older age (P<0.001), female gender (P=0.001), lower BMI (P=0.016), and lower serum albumin level (P<0.001) were independent factors associated with lower serum hemoglobin level.

Conclusions: Our data showed that anemia was an independent risk factor for mortality in COPD, and aging, lower serum albumin level, and lower BMI were independent factors associated with lower serum hemoglobin level.

Citing Articles

The impact of body mass index on mortality in COPD: an updated dose-response meta-analysis.

Tenda E, Henrina J, Setiadharma A, Felix I, Yulianti M, Pitoyo C Eur Respir Rev. 2024; 33(174).

PMID: 39603663 PMC: 11600125. DOI: 10.1183/16000617.0261-2023.


A Pilot Study on Proteomic Predictors of Mortality in Stable COPD.

Enriquez-Rodriguez C, Casadevall C, Faner R, Pascual-Guardia S, Castro-Acosta A, Lopez-Campos J Cells. 2024; 13(16).

PMID: 39195241 PMC: 11352814. DOI: 10.3390/cells13161351.


Extrapulmonary Comorbidities Associated with Chronic Obstructive Pulmonary Disease: A Review.

Xiang Y, Luo X Int J Chron Obstruct Pulmon Dis. 2024; 19:567-578.

PMID: 38476124 PMC: 10927883. DOI: 10.2147/COPD.S447739.


Use of Laboratory Tests and Their Prognostic Value in Patients with Stable Chronic Obstructive Pulmonary Disease.

Khatib S, Sabobeh T, Jaber F, Abdalla K, Singh S, Salzman G Mo Med. 2023; 119(6):545-552.

PMID: 36588649 PMC: 9762209.


Blood eosinophil count as a prognostic biomarker in COPD.

Oh Y, Lee K, Hong Y, Hwang S, Kim J, Kim D Int J Chron Obstruct Pulmon Dis. 2018; 13:3589-3596.

PMID: 30464441 PMC: 6219410. DOI: 10.2147/COPD.S179734.


References
1.
Silverberg D, Mor R, Tia Weu M, Schwartz D, Schwartz I, Chernin G . Anemia and iron deficiency in COPD patients: prevalence and the effects of correction of the anemia with erythropoiesis stimulating agents and intravenous iron. BMC Pulm Med. 2014; 14:24. PMC: 3946070. DOI: 10.1186/1471-2466-14-24. View

2.
McGarvey L, John M, Anderson J, Zvarich M, Wise R . Ascertainment of cause-specific mortality in COPD: operations of the TORCH Clinical Endpoint Committee. Thorax. 2007; 62(5):411-5. PMC: 2117197. DOI: 10.1136/thx.2006.072348. View

3.
Hwang Y, Kim C, Kang H, Shin T, Park S, Jang S . Comparison of the prevalence of chronic obstructive pulmonary disease diagnosed by lower limit of normal and fixed ratio criteria. J Korean Med Sci. 2009; 24(4):621-6. PMC: 2719218. DOI: 10.3346/jkms.2009.24.4.621. View

4.
. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002; 166(1):111-7. DOI: 10.1164/ajrccm.166.1.at1102. View

5.
Cote C, Zilberberg M, Mody S, Dordelly L, Celli B . Haemoglobin level and its clinical impact in a cohort of patients with COPD. Eur Respir J. 2007; 29(5):923-9. DOI: 10.1183/09031936.00137106. View